Novo Nordisk Board Shake-Up, Google’s OpenAI Threat, Philip Morris CEO on Earnings 10/21/25
This episode discusses the significant board shake-up at Novo Nordisk and its stock performance, fears of OpenAI competition impacting Alphabet shares, and Philip Morris CEO's breakdown of the company's earnings despite a stock decline.